News from united therapeutics corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 27, 2015, 06:00 ET United Therapeutics Corporation Reports Third Quarter 2015 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2015. "We are pleased...


Oct 21, 2015, 06:00 ET United Therapeutics Corporation To Announce Third Quarter 2015 Financial Results Before Market Open On Tuesday, October 27, 2015

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its third quarter 2015 financial results before market open on...


Oct 15, 2015, 06:00 ET United Therapeutics Announces Additional $500 Million Share Repurchase Program

United Therapeutics Corporation (NASDAQ: UTHR) today announced that its Board of Directors authorized the repurchase of up to an additional $500...


Sep 30, 2015, 06:00 ET United Therapeutics Announces Settlement of Patent Litigation with Sandoz Inc.

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Sandoz Inc. ("Sandoz") relating...


Aug 19, 2015, 06:00 ET United Therapeutics Corporation Agrees to Sell Priority Review Voucher to AbbVie for $350 Million

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into an agreement to sell its Rare Pediatric Disease Priority...


Aug 17, 2015, 06:00 ET European Commission Grants Marketing Authorisation for Unituxin™ (dinutuximab) for the Treatment of Paediatric High-Risk Neuroblastoma

United Therapeutics Corporation (NASDAQ: UTHR) announced today that the European Commission (EC) has granted Marketing Authorisation for Unituxin™...


Jul 28, 2015, 06:00 ET United Therapeutics Corporation Reports Second Quarter 2015 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2015. "Orenitram® sales...


Jul 22, 2015, 06:00 ET United Therapeutics Corporation To Announce Second Quarter 2015 Financial Results Before Market Open On Tuesday, July 28, 2015

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2015 financial results before market open on...


Jun 29, 2015, 06:00 ET Dean Judy D. Olian Joins the United Therapeutics Corporation Board of Directors

United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Dean Judy D. Olian, Ph.D. to its Board of Directors as an...


Jun 15, 2015, 09:00 ET United Therapeutics Corporation Receives Paragraph IV Notice Letter for Tyvaso

United Therapeutics Corporation (NASDAQ: UTHR) today announced receipt of a Paragraph IV Certification Notice Letter from Watson Laboratories, Inc....


May 29, 2015, 06:00 ET United Therapeutics Corporation To Present At The Jefferies 2015 Global Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United...


May 01, 2015, 06:00 ET United Therapeutics Corporation To Present At The Deutsche Bank 40th Annual Health Care Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United...


Apr 28, 2015, 06:00 ET United Therapeutics Corporation Reports First Quarter 2015 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2015. "Our total revenues...


Apr 21, 2015, 06:00 ET United Therapeutics Corporation To Announce First Quarter 2015 Financial Results Before Market Open On Tuesday, April 28, 2015

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2015 financial results before market open on...


Mar 10, 2015, 11:18 ET United Therapeutics Receives a Rare Pediatric Disease Priority Review Voucher following the Approval of Unituxin™ for Pediatric High-Risk Neuroblastoma

United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA), as part of the Biologics...


Mar 10, 2015, 11:12 ET FDA Approves Unituxin™ (dinutuximab) for the Treatment of Pediatric High-Risk Neuroblastoma

United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA) has approved Unituxin™...


Feb 25, 2015, 06:00 ET United Therapeutics Corporation To Present At The Cowen And Company 35th Annual Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer of United...


Feb 24, 2015, 06:00 ET United Therapeutics Corporation Reports 2014 Fourth Quarter And Annual Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2014. "Our...


Feb 17, 2015, 06:00 ET United Therapeutics Corporation To Announce Fourth Quarter And Annual 2014 Financial Results Before Market Open On Tuesday, February 24, 2015

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2014 financial results before...


Jan 06, 2015, 09:50 ET United Therapeutics Corporation To Present At 33rd Annual J.P. Morgan Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer, and Roger...


Dec 31, 2014, 06:00 ET United Therapeutics Announces Signing Of Agreement For New Remodulin Delivery System

United Therapeutics Corporation (NASDAQ: UTHR) announced today the signing of an agreement with DEKA Research & Development Corp. for the development ...


Dec 24, 2014, 11:26 ET United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to...


Dec 17, 2014, 06:00 ET United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change

United Therapeutics Corporation (NASDAQ: UTHR) announced today two senior executive promotions as well as changes to Martine Rothblatt, Ph.D's...


Nov 13, 2014, 06:00 ET Professor Katherine J. Klein Joins The United Therapeutics Corporation Board Of Directors

United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Professor Katherine J. Klein, Ph.D., of The Wharton School of the...


Oct 28, 2014, 06:00 ET United Therapeutics Corporation Reports Third Quarter 2014 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2014. "We are pleased...